Servier shared on LinkedIn:
“Ready for EANO 2026 in Rome?
The annual congress of the European Association of Neuro-Oncology (EANO) brings together leading clinicians, researchers, and experts in neuro-oncology from around the world to advance innovation and improve outcomes for patients with brain tumors.
- From 24 to 27 September, we will be on-site and look forward to meeting you:
- At our booth N1
- During our scientific symposiums
At Servier, we’re committed to fighting cancer and becoming an innovative player developing targeted therapies to treat cancer, such as glioma, cholangiocarcinoma, and colorectal cancer. Today, close to 70% of our R&D investment is dedicated to oncology research, reflecting our determination to bring new therapeutic options to patients who need them most.
Learn more about our commitment to oncology
We look forward to connecting with the neuro-oncology community in Rome!”
Other articles featuring Servier on OncoDaily.